<?xml version='1.0' encoding='utf-8'?>
<document id="9434282"><sentence text="Species differences of serum albumins: I. Drug binding sites." /><sentence text="The purpose of this study was the classification and identification of drug binding sites on albumins from several species in order to understand species differences of both drug binding properties and drug interaction on protein binding" /><sentence text="" /><sentence text="Binding properties and types of drug-drug interaction on the different albumins were examined using typical site I binding drugs, warfarin (WF) and phenylbutazone (PBZ), and site II binding drugs, ibuprofen (IP) and diazepam (DZ) on human albumin"><entity charOffset="148-162" id="DDI-PubMed.9434282.s4.e0" text="phenylbutazone" /><entity charOffset="164-167" id="DDI-PubMed.9434282.s4.e1" text="PBZ" /><entity charOffset="197-206" id="DDI-PubMed.9434282.s4.e2" text="ibuprofen" /><entity charOffset="208-210" id="DDI-PubMed.9434282.s4.e3" text="IP" /><entity charOffset="216-224" id="DDI-PubMed.9434282.s4.e4" text="diazepam" /><entity charOffset="226-228" id="DDI-PubMed.9434282.s4.e5" text="DZ" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e0" e2="DDI-PubMed.9434282.s4.e0" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e0" e2="DDI-PubMed.9434282.s4.e1" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e0" e2="DDI-PubMed.9434282.s4.e2" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e0" e2="DDI-PubMed.9434282.s4.e3" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e0" e2="DDI-PubMed.9434282.s4.e4" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e0" e2="DDI-PubMed.9434282.s4.e5" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e1" e2="DDI-PubMed.9434282.s4.e1" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e1" e2="DDI-PubMed.9434282.s4.e2" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e1" e2="DDI-PubMed.9434282.s4.e3" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e1" e2="DDI-PubMed.9434282.s4.e4" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e1" e2="DDI-PubMed.9434282.s4.e5" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e2" e2="DDI-PubMed.9434282.s4.e2" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e2" e2="DDI-PubMed.9434282.s4.e3" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e2" e2="DDI-PubMed.9434282.s4.e4" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e2" e2="DDI-PubMed.9434282.s4.e5" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e3" e2="DDI-PubMed.9434282.s4.e3" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e3" e2="DDI-PubMed.9434282.s4.e4" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e3" e2="DDI-PubMed.9434282.s4.e5" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e4" e2="DDI-PubMed.9434282.s4.e4" /><pair ddi="false" e1="DDI-PubMed.9434282.s4.e4" e2="DDI-PubMed.9434282.s4.e5" /></sentence><sentence text=" Equilibrium dialysis was carried out for two drugs and the free concentrations of drugs were then treated using the methods of Kragh-Hansen (Mol" /><sentence text=" Pharmacol" /><sentence text=" 34" /><sentence text=" 160-171, (1988))" /><sentence text="" /><sentence text="Binding affinities of site I drugs to bovine, rabbit and rat albumins were reasonably similar to human albumin" /><sentence text=" However, interestingly, those to dog albumin were considerably smaller than human albumin" /><sentence text=" On the other hand, binding parameters of DZ to bovine, rabbit and rat albumins were apparently different from those of human albumin"><entity charOffset="42-43" id="DDI-PubMed.9434282.s12.e0" text="DZ" /></sentence><sentence text=" These differences are best explained by microenvironmental changes in the binding sites resulting from change of size and/or hydrophobicity of the binding pocket, rather than a variation in amino acid residues"><entity charOffset="191-201" id="DDI-PubMed.9434282.s13.e0" text="amino acid" /></sentence><sentence text=" CONCLUSIONS" /><sentence text=" We will propose herein that mammalian serum albumins used in this study contain specific drug binding sites: Rabbit and rat albumins contain a drug binding site, corresponding to site I on human albumin, and dog albumin contains a specific drug binding site corresponding to site II on the human albumin molecule" /><sentence text="" /></document>